MedTrace Logo

Effects of Intranasal Oxytocin on Fear Processing in Naturalistic Contexts

NCT05892939 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2025-04-04

No results posted yet for this study

Summary

The main aim of the study is to investigate the modulatory effects of intranasal oxytocin (24IU) on fear in naturalistic social and non-social contexts and the underlying neural mechanisms.

Conditions

  • Healthy

Interventions

DRUG

intranasal Oxytocin(24IU)

Administration of intranasal Oxytocin(24IU)

DRUG

intranasal Placebo

Administration of intranasal Placebo

Sponsors & Collaborators

  • University of Electronic Science and Technology of China

    lead OTHER

Principal Investigators

  • Benjamin Becker, Dr. · University of Electronic Science and Technology of China

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-23
Primary Completion
2024-04-01
Completion
2024-04-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05892939 on ClinicalTrials.gov